MLT study materials
MLT study resources

One Positive Blood Culture Bottle in the ICU

MLT · Put your knowledge to work in context.

All case studies

One Positive Blood Culture Bottle in the ICU

A 74-year-old man is on day 4 in the ICU after emergency laparotomy for a perforated sigmoid colon. He is febrile to 38.6 °C, white cell count 16.5 x10^9/L, and has a right internal jugular central line placed on admission. Two sets of blood cultures are drawn 30 minutes apart, both from peripheral sites. At 38 hours, one anaerobic bottle from the first set turns positive; the Gram stain shows Gram-positive cocci in clusters. The companion aerobic bottle and both bottles of the second set are negative at 5 days. The isolate is coagulase-negative Staphylococcus, susceptible to vancomycin. The patient has no prosthetic material other than the central line.

1. Is this a contaminant or a true bloodstream infection? Give your reasoning.

Read the worked answer

The features favour contamination with skin flora, but this is a probabilistic judgement and must be correlated with the patient.

Points favouring contamination:

  • Only 1 of 4 bottles positive; a single bottle in a set is the classic pattern for a skin-flora contaminant introduced at venepuncture.
  • Time to positivity of 38 hours; contaminants often grow late, whereas true bacteraemia often signals within 15-24 hours.
  • The companion aerobic bottle from the same set is negative and both bottles of the second set are negative at 5 days.
  • Coagulase-negative Staphylococcus is the most common blood culture contaminant.

Points that would favour true bacteraemia:

  • The patient is genuinely febrile with leukocytosis, but he has a recent laparotomy and an intra-abdominal source, so a line infection is not required to explain the fever.
  • A central line is present, which is a risk factor for true coagulase-negative staphylococcal bacteraemia.

The pattern alone cannot decide; the clinical context and a repeat set are what convert probability into a decision.

2. What actions do you recommend, and what should you advise the ICU team about vancomycin?

Read the worked answer

Microbiology actions:

  • Report the Gram stain and preliminary identification with an explicit comment that the isolate may be a skin contaminant and that repeat cultures are recommended.
  • Do not perform full identification and susceptibility on a probable contaminant beyond what is needed, unless a second bottle grows the same organism.
  • Retain the isolate until the repeat cultures are final.

Clinical advice:

  • Draw two fresh sets of blood cultures from separate peripheral sites, ideally before any new antibiotic, and consider a set from the central line if line infection is being seriously considered.
  • Do not start, escalate, or extend vancomycin on the basis of this single bottle alone; the patient is already on antimicrobials for an intra-abdominal source.
  • Examine the line site, review the temperature curve and haemodynamics, and look for an alternative explanation for fever (anastomotic leak, intra-abdominal collection, atelectasis).
  • If a repeat set grows the same organism, or the patient deteriorates, convert to a true bacteraemia pathway and treat with vancomycin, with line removal considered.

3. What findings over the next 48 hours would make you reinterpret this as a true bloodstream infection?

Read the worked answer

Reinterpretation requires either more positive bottles or a clinical picture that a contaminant cannot explain.

Laboratory findings that would shift the interpretation:

  • The same organism growing from two or more separate sets, or from both bottles of one set.
  • Time to positivity under 24 hours on repeat culture.
  • Growth from a central-line draw with a differential time to positivity favouring the line.
  • Isolation of the same organism from another sterile site (wound, drain, prosthetic material).
  • A phenotypic or genotypic match between isolates from different sets, confirming a single strain rather than two coincidental skin contaminants.

Clinical findings:

  • Persistent fever or new haemodynamic instability with no intra-abdominal explanation.
  • New embolic phenomena, endocarditis murmur, or echocardiographic vegetations.
  • Neutropenia, immunosuppression, or a newly placed prosthetic device, which lower the threshold for treating coagulase-negative staphylococci as pathogens.
  • Failure to improve on the current antimicrobial regimen despite adequate source control.